Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dario Trapani

Showing results (11-20 of 213) with videos related to

Pageof 22
Sort By:
Current Opinion in Oncology|October 10, 2025
Progress in global breast cancer controlDario Trapani, Shilpa S Murthy
Cancer|February 10, 2023
What's the reality for CDK4/6 inhibitors: Clinical trials or real-world evidence?Dario Trapani, Erica L Mayer
Lancet (London, England)|September 21, 2024
Considerations for the CHH-Lancet Commission on Health, Conflict, and Forced DisplacementKhalid El Bairi, Dario Trapani
JCO Global Oncology|September 20, 2024
Reply to S. Najem et alKhalid El Bairi, Dario Trapani
The Lancet. Oncology|November 21, 2024
The trade-off between accelerated cancer drug approvals and patient preferencesDario Trapani, Nirmala Bhoo-Pathy
JAMA Network Open|January 31, 2025
Beyond Boundaries in ERBB2-Positive Brain Metastatic Breast CancerDario Trapani, Carmine Valenza, Giuseppe Curigliano
Biomed Research International|August 4, 2017
Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy EfficacyGiulia Viale, Dario Trapani, Giuseppe Curigliano
European Journal of Cancer (Oxford, England : 1990)|May 8, 2020
The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy RegionDario Trapani, Antonio Marra, Giuseppe Curigliano
JCO Oncology Practice|June 2, 2021
Mastering the Use of Novel Anti-HER2 Treatment OptionsPaolo Tarantino, Dario Trapani, Giuseppe Curigliano
Current Opinion in Oncology|October 1, 2025
Targeting androgen receptors in patients with metastatic breast cancerLorenzo Guidi, Dario Trapani, Giuseppe Curigliano
Pageof 22

Showing results (11-20 of 213) with videos related to

Sort By:
Pageof 22
Current Opinion in Oncology|October 10, 2025
Progress in global breast cancer controlDario Trapani, Shilpa S Murthy
Cancer|February 10, 2023
What's the reality for CDK4/6 inhibitors: Clinical trials or real-world evidence?Dario Trapani, Erica L Mayer
Lancet (London, England)|September 21, 2024
Considerations for the CHH-Lancet Commission on Health, Conflict, and Forced DisplacementKhalid El Bairi, Dario Trapani
JCO Global Oncology|September 20, 2024
Reply to S. Najem et alKhalid El Bairi, Dario Trapani
The Lancet. Oncology|November 21, 2024
The trade-off between accelerated cancer drug approvals and patient preferencesDario Trapani, Nirmala Bhoo-Pathy
JAMA Network Open|January 31, 2025
Beyond Boundaries in ERBB2-Positive Brain Metastatic Breast CancerDario Trapani, Carmine Valenza, Giuseppe Curigliano
Biomed Research International|August 4, 2017
Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy EfficacyGiulia Viale, Dario Trapani, Giuseppe Curigliano
European Journal of Cancer (Oxford, England : 1990)|May 8, 2020
The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy RegionDario Trapani, Antonio Marra, Giuseppe Curigliano
JCO Oncology Practice|June 2, 2021
Mastering the Use of Novel Anti-HER2 Treatment OptionsPaolo Tarantino, Dario Trapani, Giuseppe Curigliano
Current Opinion in Oncology|October 1, 2025
Targeting androgen receptors in patients with metastatic breast cancerLorenzo Guidi, Dario Trapani, Giuseppe Curigliano
Pageof 22